JETEMA, Co., Ltd. (KOSDAQ:216080)
7,030.00
+20.00 (0.29%)
Apr 30, 2026, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 261.58 billion as of April 30, 2026. Its market cap has decreased by -1.65% in one year.
Market Cap
261.58B
Enterprise Value
373.67B
Revenue
76.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,030.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 261.58B, an increase of 102.61%. That is a compound annual growth rate of 11.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 261.58B | 18.70% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 372.23B |
| BINEX | 368.48B |
| GC Cell | 368.16B |
| HLB Therapeutics | 321.66B |
| Bioneer | 283.14B |
| EASY BIO,Inc. | 261.68B |
| Genexine | 261.05B |
| MedPacto | 188.17B |